February 28, 2019. Phoenix, AZ. Anju Software, a clinical, medical affairs and commercial software and data platform for the life sciences industry, has received a majority investment from ABRY Partners.
Anju has delivered outstanding results for its customers and shareholders. We are joining hands with Abry to commence a new phase for the leadership team to accelerate innovation and further expedite growth. Our mantra for success is achieving optimal customer satisfaction combined with cutting edge, yet flexible products. We share the same vision with Abry and are very excited about this new partnership.Kurien Jacob on Abry, CEO, Anju Software